NEW YORK (TheStreet) -- Shares of Biocept
plummeted 36.46% to $1.15 on heavy trading volume this afternoon following the molecular oncology diagnostics company's announcement late yesterday of the pricing of 8 million shares of its common...
INDIANAPOLIS (dpa-AFX) - Aquinox Pharmaceuticals Inc. (AQXP) is expanding
its ongoing phase II clinical trials with its lead product candidate, AQX-1125.
Accordingly, the company's phase II trial of AQX-1125 in reducing pain and
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioClinica+%28BIOC%29+Announces+Clinical+Trial+Efficiency+Improvements+with+Johnson+and+Johnson+Vision+Care/6724409.html for the full story.
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/BioClinica+%28BIOC%29+Posts+Q3+non-GAAP+EPS+of+%240.07%2C+Shy+YY%3B+Revs+Heavy%3B+Reaffirms+FY10+Outlook/6071947.html for the full story.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.